These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


514 related items for PubMed ID: 11858800

  • 1. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K, Sibug RM, De Kloet ER, Barthelmebs M, Grima M, Imbs JL, De Jong W.
    Eur J Pharmacol; 2002 Feb 02; 436(3):207-16. PubMed ID: 11858800
    [Abstract] [Full Text] [Related]

  • 2. Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats.
    Rahmouni K, Barthelmebs M, Grima M, Imbs JL, Wybren De Jong.
    Hypertension; 1999 May 02; 33(5):1201-6. PubMed ID: 10334812
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats.
    Rahmouni K, Barthelmebs M, Grima M, Imbs JL, De Jong W.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):199-202. PubMed ID: 10607876
    [Abstract] [Full Text] [Related]

  • 4. Influence of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats.
    Rahmouni K, Barthelmebs M, Grima M, Imbs JL, De Jong W.
    J Hypertens; 2002 Sep 03; 20(9):1829-34. PubMed ID: 12195126
    [Abstract] [Full Text] [Related]

  • 5. Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats.
    Rahmouni K, Barthelmebs M, Grima M, Imbs JL, De Jong W.
    Hypertension; 2001 Oct 03; 38(4):902-6. PubMed ID: 11641306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
    Arai K, Morikawa Y, Ubukata N, Tsuruoka H, Homma T.
    J Pharmacol Exp Ther; 2016 Sep 03; 358(3):548-57. PubMed ID: 27384074
    [Abstract] [Full Text] [Related]

  • 8. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I, el Amrani AI, Fournié-Zaluski MC, Corvol P, Roques B, Michel JB.
    J Cardiovasc Pharmacol; 1992 Dec 03; 20(6):847-57. PubMed ID: 1282584
    [Abstract] [Full Text] [Related]

  • 9. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M, Ohtsuka K, Sakamoto M, Nanbu A, Takahashi H, Yoshimura M.
    J Hypertens; 1998 Aug 03; 16(8):1175-85. PubMed ID: 9794722
    [Abstract] [Full Text] [Related]

  • 10. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment.
    Lee YJ, Shin SJ, Tan MS, Hsieh TJ, Tsai JH.
    Am J Physiol; 1996 Oct 03; 271(4 Pt 2):F779-89. PubMed ID: 8898007
    [Abstract] [Full Text] [Related]

  • 11. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.
    Amador CA, Barrientos V, Peña J, Herrada AA, González M, Valdés S, Carrasco L, Alzamora R, Figueroa F, Kalergis AM, Michea L.
    Hypertension; 2014 Apr 03; 63(4):797-803. PubMed ID: 24420551
    [Abstract] [Full Text] [Related]

  • 12. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
    David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Rebouças NA, Tostes RC.
    Hypertension; 2001 Sep 03; 38(3 Pt 2):692-6. PubMed ID: 11566958
    [Abstract] [Full Text] [Related]

  • 13. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake.
    Vallee SM, Grillo CA, Gonzalez S, Cosen-Binker L, de Kloet ER, McEwen BS, De Nicola AF.
    Neuroendocrinology; 1995 Feb 03; 61(2):117-24. PubMed ID: 7753331
    [Abstract] [Full Text] [Related]

  • 14. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension.
    Kohzuki M, Abe K, Yasujima M, Kasai Y, Hiwatari M, Kanazawa M, Sato M, Omata K, Kudo K, Takeuchi K.
    Tohoku J Exp Med; 1989 Apr 03; 157(4):301-11. PubMed ID: 2525826
    [Abstract] [Full Text] [Related]

  • 15. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
    Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, Hilgers KF.
    Nephrol Dial Transplant; 2008 Nov 03; 23(11):3456-63. PubMed ID: 18515791
    [Abstract] [Full Text] [Related]

  • 16. No evidence for brain renin-angiotensin system activation during DOCA-salt hypertension.
    Uijl E, Ren L, Mirabito Colafella KM, van Veghel R, Garrelds IM, Domenig O, Poglitsch M, Zlatev I, Kim JB, Huang S, Melton L, Hoorn EJ, Foster D, Danser AHJ.
    Clin Sci (Lond); 2021 Jan 29; 135(2):259-274. PubMed ID: 33404046
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
    Arai K, Homma T, Morikawa Y, Ubukata N, Tsuruoka H, Aoki K, Ishikawa H, Mizuno M, Sada T.
    Eur J Pharmacol; 2015 Aug 15; 761():226-34. PubMed ID: 26073023
    [Abstract] [Full Text] [Related]

  • 18. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
    Dai SY, Peng W, Zhang YP, Li JD, Shen Y, Sun XF.
    J Neuroinflammation; 2015 Mar 08; 12():47. PubMed ID: 25885968
    [Abstract] [Full Text] [Related]

  • 19. [Brain mineralocorticoid receptor and blood pressure control in the conscious normotensive rat].
    Rahmouni K, Barthelmebs M, Imbs JL, De Jong W.
    Arch Mal Coeur Vaiss; 1998 Aug 08; 91(8):1009-12. PubMed ID: 9749155
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.